Bellevue Group Ag Portfolio Holdings

Bellevue Group Ag

  • $5.02 Billion
  • Q4 2024

Bellevue Group Ag has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $5.02 Billion distributed in 193 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $365M, Ionis Pharmaceuticals Inc with a value of $275M, Neurocrine Biosciences Inc with a value of $248M, Intuitive Surgical Inc with a value of $242M, and Intra Cellular Therapies, Inc. with a value of $204M.

Examining the 13F form we can see an decrease of $914M in the current position value, from $5.93B to 5.02B.

Bellevue Group Ag is based out at Kuesnacht, V8

Below you can find more details about Bellevue Group Ag portfolio as well as his latest detailed transactions.

Portfolio value $5.02 Billion
Healthcare: $5.01 Billion
ETFs: $4.21 Million
Communication Services: $1.31 Million
Technology: $577,000

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$3.32 Million 0.07% of portfolio
5,660
Q4 2024 New
$0
$888,000 0.02% of portfolio
26,200
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 193
  • Current Value $5.02 Billion
  • Prior Value $5.93 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 12 stocks
  • Additional Purchases 50 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 68 stocks
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email